Intelligence Β· Patent portfolio
United Therapeutics Europe Patents
Full USPTO pharma patent portfolio for United Therapeutics Europe β grant dates, expiration, and drug cross-links.
- Patents
- 3,720
- Expiring β€24m
- 234
Quick answer
United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β use filters for patent-cliff planning.
-
US 6194388
Immunomodulatory oligonucleotides
expired -
US 6190859
Method and kit for detection of dengue virus
expired -
US 6190656
Immunologic enhancement with intermittent interleukin-2 therapy
expired -
US 6187745
Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus
expired -
US 6187775
Acridone-derived compounds useful as antineoplastic and antiretroviral agents
expired -
US 6187306
Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same
expired -
US 6184339
High strength polymeric networks derived from (meth) acrylate resins with organofluorine content and process for preparing same
expired -
US 6183752
Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
expired -
US 6184246
Inhibition of cytokine production by polymethoxylated flavones
expired -
US 6184024
Chimeric and/or growth-restricted flaviviruses
expired -
US 6180110
Attenuated hepatitis a virus vaccine which grows in MRC-5 cells
expired -
US 6177434
Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms
expired -
US 6177534
Silylated resins and the synthesis thereof
expired -
US 6177415
Bacteriohopanetetrol and related compounds useful for modulation of lipoxygenase activity and anti-inflammatory applications
expired -
US 6174666
Method of eliminating inhibitory/instability regions from mRNA
expired -
US 6174862
Neurotrophic peptides of activity dependent neurotrophic factor
expired -
US 6172070
Substituted O6-benzyl-8-aza-guanines and 6(4)-benzyloxypyrimidines
expired -
US 6171803
Isolation, characterization, and use of the human .beta. subunit of the high affinity receptor for immunoglobulin E
expired -
US 6171596
Oligomeric HIV-1 envelope glycoproteins
expired -
US 6165781
Modified adeno-associated virus vector capable of expression from a novel promoter
expired -
US 6165460
Generation of immune responses to prostate-specific antigen (PSA)
expired -
US 6162897
17q-linked breast and ovarian cancer susceptibility gene
expired -
US 6159958
Treatment or prophylaxis of retinal pathology and spinal cord injury
expired -
US 6156765
Method of treating and preventing vasospasm
expired -
US 6153430
Nucleic acid encoding mesothelin, a differentiation antigen present on mesothelium, mesotheliomas and ovarian cancers
expired -
US 6153202
In ovo methods for utilizing live Edwardsiella ictaluri against enteric septicemia in channel catfish
expired -
US 6153421
Cloned genomes of infectious hepatitis C viruses and uses thereof
expired -
US 6153589
2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents
expired -
US 6150398
Methods for the treatment of cancer
expired -
US 6150581
Chitosan/alginate anti-adhesion barrier
expired -
US 6146643
Human/simian chimeric hepatitis A virus vaccine
expired -
US 6146641
Avian leukosis virus subgroup J envelope gene product for diagnosis and immunogenic composition
expired -
US 6147203
Recombinant disulfide-stabilized polypeptide fragments having binding specificity
expired -
US 6143304
Enhanced yield of podophyllotoxin from natural products through in situ conversion methods
expired -
US 6143910
Methods for preparation and use of 1.alpha., 24(S) -dihydroxy vitamin D2
expired -
US 6140339
Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
expired -
US 6132732
Parvovirus capsids
expired -
US 6132980
Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes
expired -
US 6126944
Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus
expired -
US 6127578
Method of altering sphingolipid metabolism and detecting fumonisin ingestion and contamination
expired -
US 6120988
Method of detecting hev infection
expired -
US 6117427
Vaccines and methods for preventing and treating fescue toxicosis in herbivores
expired -
US 6117640
Recombinant vaccine made in E. coli against dengue virus
expired -
US 6117991
Biologically active synthetic thyrotropin and cloned gene producing same
expired -
US 6114397
Gossypol for the treatment of cancer
expired -
US 6113912
Hepatitis A virus vaccines
expired -
US 6114156
Molecular level coating for metal oxide particles
expired -
US 6110453
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
expired
Frequently asked questions
How many patents does United Therapeutics Europe have?
3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do United Therapeutics Europe patents expire?
234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory